The global clinical decision support systems market size was valued at USD 4.9 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.6% from 2023 to 2030. The rising demand for quality care and integrated reliable technical solutions is one of the key trends escalating market growth. Increasing adoption of information systems by hospitals and healthcare institutes and favorable initiatives taken by several governments worldwide are also stimulating the growth of the market.
Clinical decision support systems (CDSS) are strictly regulated by authorities such as the FDA. Therefore, platforms introduced or in developmental phases are expected to fulfill relevant criteria set by FDA & CE Mark. In addition, competitors have to take into account the non-violation of information technology and cyber laws to assure the integrity of products.
CDSS vendors and organizations have undertaken initiatives to help curb the pandemic. CDSS has become a vital tool in the fight against COVID-19, as it showed how healthcare teams can stay on top of the latest COVID information and intelligence, helping advance the quality of the care they provide. The Infectious Diseases Society of America endorsed repeating a COVID-19 test in patients with a moderate-to-high probability of COVID-19. However, there was little direction about what factors cause a patient to have a low or high probability of contracting the infection.
A team of infectious disease specialists at Massachusetts General Hospital worked around the clock. Thus, dedicated efforts led to the development of a CDS tool called COvid Risk cALculator (CORAL). The tool is embedded within the EHR. This is expected to positively impact market growth. Moreover, in October 2020, CORAL, an outpatient version, was introduced. CORAL remained exclusive as the only algorithm that has been combined into routine, prospective clinician workflow through an EHR CDSS.
Rapid advancements in the fields of biotechnology and bioinformatics are encouraging improvements and optimizations in data storage, management, and analytics platforms. The marketplace is anticipated to witness a large number of innovations following R&D projects backed up by large corporate investments. Integration of cloud computing and interoperability platforms in different systems will further promote smooth functioning and seamless data flow, thereby revving up the adoption of CDSS.
In recent years, there has been substantial growth in the number of hospitals and healthcare facilities adopting various types and levels of clinical decision support systems, indicating a significant potential for increased deployment. In industrialized regions, demand for decision assistance based on factual evidence and real-time knowledge has increased at a faster rate. CDSS makes physical order entry easier by allowing physicians to choose from a database of prescriptions. The growing number of patients in clinics and hospitals has made it more difficult to keep track of and manage data for each one.
Over the past few years, the development of collaborations among CDSS providers & hospitals has witnessed a significant surge. Government recognition and initiatives to encourage the adoption of CDSS and EHR systems are estimated to further increase demand. Integration with Electronic Health Records (EHR) improves the efficiency of clinical care by reducing the time to search for a patient’s history and clinical records.
Furthermore, the U.S. Government's Health and Medicare Acts have endorsed CDSS, financially rewarding CDS integration into EHRs (Electronic Health Records). In 2013, around 41% of U.S. hospitals having an EHR also had a CDSS, while 40.2% of U.S. hospitals had cutting-edge CDS capability in 2017. In addition, companies are involved in partnerships to develop and provide software updated with the latest information.
Clinical decision-making is a complicated task that requires a knowledgeable practitioner, a supportive environment, and reliable informational inputs. The difficulty faced in quality clinical decision-making by healthcare entities can be addressed with the implementation of CDSS as a supportive tool. The emergence of CDSS has been recognized as an important solution to overcome issues in delivering high-quality care to patients by improving and streamlining the quality of healthcare delivery.
Standalone CDSS held the largest market share of over 31.00% in 2022, as it is widely adopted due to its low cost and simplicity. Ease of use in hospitals and clinical settings has contributed to its highest share. The standalone segment will continue to dominate the market throughout the forecast period. CDSS products are available either standalone, or integration with EHR or CPOE, or both.
Integrated EHR with CDSS segment is poised to show lucrative growth through 2030. Growing awareness and adoption of EHR by multi-specialty health care units is poised to influence the share of CDSS integrated with EHR. These systems provide patient database and history to CDSS, which can provide clinical solutions and suggest medication to the practitioner, thus automating the clinical workflow. CDSS and EHRs are often integrated to streamline workflows and make use of present data sets. There is a rising number of CDSS functions built into EHR systems, which is expected to support segment growth.
Drug allergy alerts accounted for the largest market share of over 26.0% in 2022. Several people have allergies to some specific drugs, and consequently, it is important to have systems that provide allergy alerts. The burden of allergies, i.e., drug allergies, is rising. In the process of prescribing, dispensing, or administering a drug, a medicine error may happen and can have adverse outcomes, e.g., medication may be given to a patient with a documented allergy to that drug.
The clinical guidelines segment is anticipated to show lucrative growth during the projection period. The CDS system offers guidelines for treatment and diagnosis. It retrieves data from the knowledge base and utilizes it for treatment, providing the practitioner with clinical guidelines to be followed during the treatment course, thus improving the quality of care.
CDSS services held the largest market share of over 42.6% in 2022. This is due to timely up-gradation of software as well as the knowledge base available for use. Services in CDSS involve the maintenance of components and their accessories. It includes hardware & software upgrades, as well as providing a knowledge database with the latest innovations & recent medications.
CDSS software segment is anticipated to show lucrative growth during the assessment period. The CDSS software, when used in integration with software for CPOE and EHRs, provides enhanced decision support by making customized and specific results for the particular patient. Novel innovations for technical support and interoperability of the software are anticipated to drive the market during the projection years.
Cloud-based systems held the second largest market share in 2022 of around 34%, owing to significant innovations in information technology, with potential applications in the healthcare sector. Reliability and cost-efficiency are major factors that contribute to the growth of this segment.
The primary services provided under cloud computing are Platform as a Service (PaaS), which creates a platform, i.e., develops an OS to run the software; Infrastructure as a Service (IaaS), which uses virtual technology to create a user interface to provide the services; and Software as a Service (SaaS), which forms the most critical aspect of the cloud provider, as it enables them to operate, install, & manage software to provide services to the end-user.
CDSSs require access to healthcare data and knowledge which is stored in a database. Data stored on the web is easily accessible through mobile and computer devices. Web-based devices use the data stored on the web to provide decision support to medical practitioners. Technological innovation has enabled the designing of web-based systems for the accurate diagnosis of different health conditions. For instance, Net Decision Support System is a web-based system that offers support for depression management.
The North American region dominated the global CDSS market in 2022 with over 44.4% revenue share; the region comprises the U.S. and Canada. Its market lead can be attributed to the surging demand for healthcare information technology solutions in the medical sector. Rapid technological advancements and the growing importance of providing quality healthcare services are further contributing to market growth in this region.
Asia Pacific is anticipated to be the fastest-growing region in the global CDSS market. This can be attributed to increasing investments in the healthcare sector in countries such as Australia, China, India, and Japan. Asia Pacific’s market is showing high potential due to increasing R&D expenditure by governments of key economies for increasing the penetration of information technology in the medical field. In addition, the increasing geriatric population pool is likely to serve as a key factor fueling the regional market.
The global clinical decision support systems market is fairly competitive. The most notable participants in the market are McKesson Corporation; Philips Healthcare; Wolters Kluwer NU; Cerner Corporation; Siemens Healthineers., along with other providers of clinical decision support systems. These players are involved in new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other.
For instance, in April 2021, Change Healthcare revealed InterQual 2021, the newest version of the corporation’s flagship CDS solution. This release features four innovative Medicare criteria elements along with a substantial amount of evidence-based content updates and enhancements, comprising new guidance for COVID-19 patients, addressing social factors of health, and suitable usage of telehealth.
Moreover, in May 2020, DHIndia announced a partnership with EHRC@IIITB & Healthelife to develop a CDSS for the screening of COVID-19. The partnership also included the formation of a minimal triage application for front-line doctors. Some of the prominent players in the global clinical decision support systems market include:
Siemens Healthineers GmbH
Allscripts Healthcare, LLC
NextGen Healthcare Inc.
Koninklijke Philips N.V. (Royal Philips)
Wolters Kluwer N.V.
Market size value in 2023
USD 5.3 billion
Revenue forecast in 2030
USD 10.7 billion
CAGR of 10.6% from 2023 to 2030
Base year for estimation
Actual estimates/Historical data
2017 - 2021
2023 - 2030
Revenue in USD million & CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, application, delivery mode, component, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Denmark: Sweden; Norway; Japan; India; China; Australia; South Korea; Thailand; Brazil; Mexico; Argentina, South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
McKesson Corporation; Cerner Corporation; Siemens Healthineers GmbH; Allscripts Healthcare, LLC; athenahealth, Inc.; NextGen Healthcare Inc.; Koninklijke Philips N.V. (Royal Philips); IBM Corporation; Agfa-Gevaert Group; Wolters Kluwer N.V.
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global clinical decision support systems market report on the basis of product, application, delivery mode, component, and region:
Product Outlook (Revenue, USD Million, 2017 - 2030)
Integrated CPOE with CDSS
Integrated EHR with CDSS
Integrated CDSS with CPOE & EHR
Application Outlook (Revenue, USD Million, 2017 - 2030)
Drug allergy alerts
Drug dosing support
Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)
On -premise Systems
Component Outlook (Revenue, USD Million, 2017 - 2030)
Regional Outlook (Revenue, USD Million, 2017 - 2030)
b. The global clinical decision support systems market size was estimated at USD 4.9 billion in 2022 and is expected to reach USD 5.3 billion in 2023.
b. The global clinical decision support systems market is expected to grow at a compound annual growth rate of 10.6% from 2023 to 2030 to reach USD 10.7 billion by 2030.
b. North America dominated the clinical decision support systems market with a share of 44.4% in 20222. This is attributable to rapid technological advancements, a growing emphasis on quality healthcare services, and surging demand for healthcare information technology solutions in the medical sector.
b. Some key players operating in the clinical decision support systems market include Agfa Healthcare; McKesson Corporation; NextGen Healthcare Information Systems; Medical Information Technology Inc.; Carestream Health Inc.; AthenaHealth; Philips Healthcare; Wolters Kluwer NU; Cerner Corporation; and Siemens Healthineers.
b. Key factors that are driving the clinical decision support systems market growth include rising demand for quality care and integrated reliable technical solutions. Increasing adoption of information systems by hospitals and healthcare institutes and favorable initiatives taken by several governments worldwide are also stimulating the growth of the market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."